The future of Pharma and biotech is unfolding now. Biopharma companies have pressure to improve operational excellence, enable cost efficiency and fuel growth through innovation. Along the value chain patients, physicians, payers, pharmacists, regulators, and government authorities are expecting affordable prices and greater value of the therapies.
The concrete manifesto of this trend is the shift from treatment to prevention, diagnostics and cure. Thus, innovative playing fields are emerging with regard to digitalization; new therapies such as genetics and immunotherapy; technological advances such as 3D printing, bionics, predictive analysis and nanotechnology; patients’ empowerment and access to data.
In order to master these disruptions and maintain influence and earnings, biopharma companies need to recruit, develop and retain talents capable to drive organizational transformations, build-up strategic partnerships, orchestrate new business models and harness M&A opportunities. We help biopharma companies to exceed their expectations by hiring the 5% high-potential leaders required.